<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02012244</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0044</org_study_id>
    <nct_id>NCT02012244</nct_id>
  </id_info>
  <brief_title>Effects of Postoperative Pain Management on Immune Function After Laparoscopic Resection of Colorectal Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Severance Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare postoperative immune function (e.g. NK cell activity)
      of fentanyl-based analgesic regimen versus local anesthetic wound infiltration-based
      anlagesic regimen after laparoscopic colorectal surgery
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>NK cell activity</measure>
    <time_frame>48 hours</time_frame>
    <description>NK cell activity : preoperation, POD 1, POD 2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IL-2</measure>
    <time_frame>48 hours</time_frame>
    <description>IL-2 level : preoperation, POD 1, POD 2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complication and recurrence</measure>
    <time_frame>1 year</time_frame>
    <description>Postoperative complication, recurrence</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Inflammatory responses</measure>
    <time_frame>48 hours</time_frame>
    <description>White blood cell, neutrophil, C-reactive protein (CRP) : preoperation, POD 1, POD 2</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Colorectal Surgery</condition>
  <arm_group>
    <arm_group_label>fentanyl-based analgesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>fentanyl intravenous patient-controlled analgesia + additional pethidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local anesthetic wound infiltration-based anlagesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>continuous wound inflitration with ropivacaine + tramadol intravenous patient-controlled analgesia + additional ketorolac or propacetamol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fentanyl-based analgesia</intervention_name>
    <description>fentanyl based patient-controlled analgesia + additional pethidine for postoperative 48 hour</description>
    <arm_group_label>fentanyl-based analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>local anesthetic wound infiltration-based anlagesia</intervention_name>
    <description>continuous wound inflitration with ropivacaine + tramadol patient-controlled analgesia + additional ketorolac or propacetamol for postoperative 48 hour</description>
    <arm_group_label>local anesthetic wound infiltration-based anlagesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA class I-III

          -  20-80 years old

          -  elective laparoscopic colorectal surgery for cancer

        Exclusion Criteria:

          -  drug allergy

          -  significant renal or hepatic impairment

          -  sign of infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine</name>
      <address>
        <city>Sedoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2013</study_first_submitted>
  <study_first_submitted_qc>December 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2013</study_first_posted>
  <last_update_submitted>January 10, 2016</last_update_submitted>
  <last_update_submitted_qc>January 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Severance Hospital</investigator_affiliation>
    <investigator_full_name>So Yeon Kim</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>analgesia; colorectal surgery; immunity; local anesthetics; opioids</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

